Home > Newsletters > International Pharmaceutical Regulatory Monitor > China Shutters Shoddy Drugmakers in Wake of Chromium Capsule Scare
International Pharmaceutical Regulatory Monitor
June 2012 | Vol. 40 No. 6
China Shutters Shoddy Drugmakers in Wake of Chromium Capsule Scare
A number of drugmakers in China are being ordered to power down production lines and hand over their licenses for producing capsule-based drugs after a crackdown on chromium contamination by the country’s regulatory agency.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.